Bernard Thorens will manage the RHAPSODY project
The stated goal of RHAPSODY is to define a molecular taxonomy of type 2 diabetes mellitus (T2D) that will support patient segmentation, inform clinical trial design, and the establishment of regulatory paths for the adoption of novel strategies for diabetes prevention and treatment.
The Prof. Bernard Thorens from the Center of Integrative Genomics of the University of Lausanne, Switzerland and Member of LIMNA board of director will manage the project.